Shares of Qiagen have rebounded after three years following a news report that the provider of biotech workflow solutions was evaluating strategic options, which include a potential sale.
The National Nuclear Security Administration (NNSA) is celebrating “a significant milestone,” announcing that it completed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results